hammoud Disseminated fungal infection 5232013 hammoud Amir Ali soultani A 4 year old boy who was admitted in 7192 due to fever abdominal pain and anorexia since 3 weeks CBC WBC350010 blastHb8PLT ID: 269074
Download Presentation The PPT/PDF document "5/23/2013" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
5/23/2013
hammoudSlide2
Disseminated fungal infection
5/23/2013
hammoudSlide3
Amir Ali
soultani
A 4 year old boy who was admitted in 7-1-92 , due to fever ,abdominal pain , and anorexia since 3 weeks.CBC: WBC:3500(10% blast)-Hb:8-PLT:BMA: full blast- ALL CD10,19,22: +
5/23/2013
hammoudSlide4
During the last days of induction (prednisone tapering) he had signs of septic shock and was transferred to ICU:
Hypotension
FeverARDSPleural effusion
DIC
Respiratory distress
5/23/2013
hammoudSlide5
B/C:
klebsiella
pneumonia S: Tazosin-Cipro-Amika R: Meropnem
5/23/2013
hammoudSlide6
After clinical and lab recovery, the patient had fever and cough
CT: disseminated pulmonary nodules and hypo dense lesions in spleen and kidney compatible with IFI
5/23/2013
hammoudSlide7
Since the patient was on
voriconazole
for 2 weaks , he was treated with Ampho+ caspoGalactomannan: 0.9 before sepsis
2.4-2.5 (BAL-blood)
5/23/2013
hammoudSlide8
BEFORE
AMPHO +CASPHO
5/23/2013
hammoudSlide9
5/23/2013
hammoudSlide10
5/23/2013
hammoudSlide11
5/23/2013
hammoudSlide12
5/23/2013
hammoudSlide13
5/23/2013
hammoudSlide14
5/23/2013
hammoudSlide15
5/23/2013
hammoudSlide16
5/23/2013
hammoudSlide17
5/23/2013
hammoudSlide18
5/23/2013
hammoudSlide19
AFTER
AMPHO +CASPHO
5/23/2013
hammoudSlide20
5/23/2013
hammoudSlide21
5/23/2013
hammoudSlide22
5/23/2013
hammoudSlide23
5/23/2013
hammoudSlide24
5/23/2013
hammoudSlide25
5/23/2013
hammoudSlide26
5/23/2013
hammoudSlide27
Is there any relation between bacterial sepsis and IFI?
What is the preferred anti fungal therapy?
5/23/2013
hammoudSlide28
5/23/2013
hammoudSlide29
5/23/2013
hammoudSlide30
UP TO DATE
Caspofungin
: Caspofungin, an echinocandin
, has been approved by the US FDA for the treatment of invasive aspergillosis in patients who cannot tolerate or who are refractory to standard therapy
.
It
is not utilized for primary therapy of invasive
aspergillosis
because of a lack of data in this setting; it is used for salvage therapy, often in combination with another antifungal drug
5/23/2013
hammoudSlide31
UP TO DATE
Liposomal amphotericin B and
caspofungin : Prior to the availability of
voriconazole, there was substantial interest in combination regimens of liposomal amphotericin B (AmBisome
) and
caspofungin
for invasive
aspergillosis
.
This
combination has shown some benefit compared with liposomal amphotericin
monotherapy
, but has not been compared with
voriconazole
monotherapy
5/23/2013
hammoudSlide32
FEIGIN
GALACTOMANNAN ANTIGEN
TESTING:Galactomannan (GM) is a
major cell wall component of Aspergillus, and
the highest concentrations of GM are always released in the terminal phases of the
diseas
5/23/2013
hammoud